virus
util
host
factor
effici
prolifer
evalu
inhibitori
effect
compound
librari
identifi
inhibitor
cyclophilin
cypa
known
immunosuppressor
peptidylprolyl
cistran
isomeras
activ
significantli
attenu
prolifer
demonstr
cypa
play
essenti
role
entri
rna
interferencemedi
reduct
endogen
cypa
express
led
decreas
multipl
reveal
cypa
directli
interact
modifi
conform
hi
loop
protein
capsid
thu
regul
uncoat
process
entri
step
phdepend
manner
result
aid
understand
host
factor
influenc
life
cycl
provid
new
potenti
target
develop
antivir
agent
infect
cyclophilin
cyp
key
cellular
factor
function
numer
cellular
process
includ
transcript
regul
immun
respons
protein
secret
mitochondri
function
cyp
possess
peptidylprolyl
cistran
isomeras
activ
high
affin
immunosuppress
cyclosporin
csa
cyclophilin
cypa
key
member
cyp
famili
first
shown
mediat
immunosuppress
function
csa
format
csacypa
complex
complex
bind
inhibit
function
phosphatas
calcineurin
normal
function
dephosphoryl
nfat
transcript
factor
import
cell
activ
cypa
also
known
play
critic
role
prolifer
number
virus
includ
human
immunodefici
viru
type
influenza
viru
hepat
c
viru
hcv
vesicular
stomat
viru
vsv
vaccinia
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
rotaviru
rv
human
papillomaviru
hpv
interact
viral
protein
facilit
ifnb
product
cypa
first
shown
incorpor
virion
interact
capsid
protein
ca
interact
newli
synthes
ca
cypa
requir
induc
dendrit
cell
matur
cypa
also
interact
protein
vpr
regul
hiv
infect
cypa
reveal
interact
extracellular
main
receptor
cypa
cell
membran
human
leukocyt
interact
induc
phosphoryl
matrix
protein
regul
liber
revers
transcriptas
complex
cytoplasm
earli
stage
infect
function
attach
host
cell
recent
research
show
cypa
stabil
capsid
antagon
uncoat
vitro
indic
versatil
role
cypa
infect
moreov
sever
line
evid
reveal
cyp
play
crucial
role
hcv
life
cycl
cypb
first
report
import
hcv
replic
later
studi
show
cypa
cypb
requir
hcv
infect
vitro
cypa
report
function
replic
hcv
increas
affin
hcv
polymeras
viral
rna
enhanc
hcv
replic
bind
hcv
protein
aid
viral
replic
furthermor
cyp
demonstr
play
essenti
role
hpv
infect
facilit
conform
chang
capsid
protein
hpv
result
exposur
nterminu
protein
dissoci
pentam
recombin
complex
phdepend
manner
member
picornavirida
famili
one
major
caus
agent
handfootandmouth
diseas
hfmd
pan
asiapacif
region
result
eight
million
infect
three
thousand
dead
case
sinc
genom
contain
singlestrand
positivesens
rna
ssrna
encod
polypeptid
molecular
weight
approxim
kda
polyprotein
initi
process
one
structur
two
nonstructur
region
undergo
proteolyt
cleavag
variou
precursor
ultim
result
matur
protein
among
proteolyz
form
viral
capsid
process
replicas
protein
product
infect
virion
must
uncoat
releas
viral
genom
host
cytoplasm
follow
success
bind
function
receptor
enterovir
uncoat
process
involv
sequenti
capsid
alter
conform
chang
uncoat
matur
particl
sediment
coeffici
convert
uncoat
intermedi
particl
sediment
coeffici
subsequ
empti
particl
repres
final
product
entri
process
particl
empti
particl
shed
genom
rna
wherea
particl
retain
full
complement
genom
rna
lack
content
extern
ntermin
extens
normal
insid
virion
involv
host
cellular
factor
play
essenti
role
viru
prolifer
howev
knowledg
util
host
factor
life
cycl
limit
two
extracellular
membran
protein
human
pselectin
glycoprotein
scaveng
receptor
well
heparan
sulfat
hs
recent
identifi
function
receptor
infect
anoth
result
suggest
bind
human
annexin
ii
cell
surfac
enhanc
viral
entri
infect
especi
low
infect
dose
interestingli
report
exclus
uncoat
receptor
trigger
convers
particl
form
uncoat
process
acid
condit
result
releas
viral
genom
use
cypa
inhibitor
bioprob
show
cypa
play
essenti
role
prolifer
also
elucid
mechan
cypa
interact
modifi
conform
hi
loop
thu
regul
uncoat
process
entri
capsid
function
associ
provid
inform
understand
cellular
factor
use
infect
also
present
new
promis
potenti
develop
antivir
therapeut
compound
collect
includ
chemic
synthes
compound
screen
use
rhabdomyosarcoma
rd
cell
infect
viru
strain
screen
identifi
compound
fig
potent
inhibitor
viral
prolifer
ec
valu
nm
measur
viru
rna
quantit
rtpcr
qrtpcr
fig
signific
cytotox
observ
compound
concentr
mm
demonstr
assay
fig
indic
inhibit
prolifer
specif
compound
previous
report
function
cypa
inhibitor
next
select
csa
fig
wellknown
cyp
inhibitor
clinic
immunosuppress
drug
antivir
effect
suppress
hcv
replic
check
whether
cypa
inhibitor
also
inhibit
replic
result
reveal
csa
clearli
impair
prolifer
ec
valu
mm
fig
howev
csa
slightli
higher
cytotox
fig
cyp
known
involv
viral
life
cycl
interest
identifi
host
factor
life
cycl
antivir
agent
prompt
us
initi
investig
studi
work
mechan
cypa
life
cycl
inhibitori
mechan
cyp
inhibitor
block
replic
cypa
play
critic
role
viru
prolifer
ten
subfamili
identifi
cyp
famili
date
among
cypa
cypb
abund
subtyp
clarifi
type
cyp
essenti
prolifer
next
use
rna
interfer
rnai
method
investig
impact
cypa
cypb
viru
prolifer
first
introduc
short
hairpin
rna
shrna
design
recogn
noncod
region
cypa
shcypa
cypb
shcypb
lentivir
vector
rd
cell
downregul
endogen
cypa
cypb
express
express
dehydrogenas
gapdh
housekeep
gene
use
intern
control
downregul
fig
obtain
stabl
knockdown
cell
line
resist
gene
screen
infect
shrnard
cell
appli
viru
multipl
infect
moi
result
flow
cytometr
studi
reveal
rd
cell
neg
control
shrna
rdshcontrol
infect
viru
infect
ratio
decreas
rdshcypa
cell
howev
infect
rate
remain
rdshcypb
cell
suggest
cypa
dominantli
impact
infect
fig
moreov
infect
multipl
infect
moi
rna
level
cypa
knockdown
cell
diminish
approxim
level
observ
rdshcontrol
cell
wherea
cypb
knockdown
result
reduct
fig
also
infect
rdshcypa
rdshcypb
cell
enteroviru
major
caus
agent
handfootandmouth
diseas
hfmd
asiapacif
region
caus
one
million
infect
case
nine
hundr
death
year
china
mainland
known
infect
young
children
sake
undevelop
immun
system
unlik
enteroviru
eg
coxsackieviru
could
caus
sever
asept
mening
enceph
myocard
acut
flaccid
paralysi
thu
lead
high
fatal
rate
clinic
appli
therapeut
work
use
cypa
inhibitor
bioprob
show
cypa
play
essenti
role
prolifer
also
elucid
mechan
cypa
interact
hi
loop
function
uncoat
regul
entri
step
sinc
sever
nonimmunosuppress
cypa
inhibitor
eg
report
show
antivir
potenc
result
provid
potenti
way
discov
clinic
therapeut
infect
moi
respect
result
reveal
similar
find
one
caus
infect
moi
fig
furthermor
express
level
protein
major
compon
capsid
significantli
reduc
knockdown
cypa
cypb
consist
impact
cypa
reduct
rna
level
fig
left
half
interest
observ
cypb
knockdown
result
small
increas
rna
replic
express
fig
verifi
impact
cypa
differ
cell
line
use
infect
gener
addit
stabl
cypa
knockdown
cell
line
observ
infect
moi
cell
neg
control
shrna
result
demonstr
decreas
rna
replic
fig
express
fig
similar
rd
cell
line
taken
togeth
data
suggest
loss
cypa
function
specif
associ
inhibit
prolifer
previou
studi
suggest
cypa
upregul
viru
infect
correl
final
result
infect
similarli
express
host
cell
cypa
upregul
rd
cell
follow
infect
fig
also
found
infect
led
minor
alter
secret
cypa
supernat
rdshcontrol
cell
littl
cypa
could
detect
rdshcypa
cultur
without
infect
fig
find
indic
cypa
present
host
cell
secret
supernat
cypa
upregul
follow
infect
cypa
found
interact
differ
viral
protein
affect
differ
stage
viral
life
cycl
distinct
mechan
defin
work
target
cypa
viru
gener
viru
resist
cypa
inhibitor
multipl
cell
cultur
passag
presenc
compound
sequenc
analys
entir
genom
multipl
resist
virus
identifi
singl
ttoc
mutat
nucleotid
posit
genom
tabl
mutat
translat
singl
amino
acid
substitut
serin
prolin
residu
residu
number
correspond
residu
sequenc
protein
polypeptid
locat
hi
loop
confirm
mutant
mutat
contribut
resist
phenotyp
select
mutant
viru
engin
recombin
mutant
viru
wild
type
strain
introduct
singl
serinetoprolin
substitut
posit
investig
sensit
viru
compound
csa
comparison
ec
valu
compound
prolifer
mm
approxim
higher
ec
valu
ec
valu
csa
higher
mutat
viru
tabl
moreov
follow
infect
drugresist
recombin
viru
rna
level
rdshcypa
cell
approxim
level
rdshcontrol
cell
valu
much
higher
valu
observ
rdshcypa
cell
infect
viru
approxim
suggest
mutant
rescu
replic
express
level
protein
also
consist
recov
normal
level
follow
infect
viru
fig
right
half
data
reveal
mutant
specif
associ
resist
cypa
inhibitor
cypa
peptidylprolyl
cistran
isomeras
activ
facilit
conform
modif
prolin
residu
examin
protein
sequenc
found
one
prolin
residu
locat
close
posit
ie
hypothes
resist
mutat
serin
residu
prolin
residu
posit
may
increas
bind
affin
cypa
help
viru
escap
drug
treatment
deplet
endogen
cypa
clarifi
mechan
underli
cypa
regul
life
cycl
analyz
molecular
interact
cypa
virion
hi
loop
use
gst
pulldown
assay
first
check
whether
recombin
cypa
protein
could
associ
virion
fig
use
gsttag
cypa
probe
fig
demonstr
recombin
cypa
protein
clearli
bound
interact
cypa
virion
increas
substitut
prolin
residu
fig
upper
panel
howev
replac
alanin
residu
mutat
viru
ie
bind
cypa
fig
bottom
panel
interact
cypa
virion
also
reduc
dosedepend
manner
treat
csa
almost
abolish
concentr
mm
csa
fig
upper
panel
addit
mutant
rescu
interact
cypa
csa
treatment
fig
bottom
panel
demonstr
recombin
cypa
protein
bound
strain
also
strain
viru
fig
also
use
nmr
spectra
demonstr
recombin
cypa
bind
chemic
synthes
hi
loop
peptid
caus
chemic
shift
chang
suggest
cypa
catalyz
correct
cistran
reaction
hi
loop
fig
moreov
report
catalyticdefect
mutant
cypa
call
elimin
interact
cypa
virion
fig
similar
attenu
interact
cypa
mutant
virion
also
report
hcv
taken
togeth
result
reveal
cypa
function
directli
hi
loop
replac
serin
prolin
posit
could
increas
bind
affin
cypa
virion
cypa
function
entri
step
infect
locat
hi
loop
protein
viru
sever
loop
region
protein
known
play
critic
role
entri
step
picornaviru
infect
therefor
hypothes
cypa
may
also
act
entri
step
life
cycl
verifi
hypothesi
first
infect
rd
cell
treat
mm
compound
h
postinfect
hpi
hpi
indic
suppli
viru
infect
inhibitor
result
show
inhibit
repres
clear
depend
treatment
time
treatment
hpi
show
inhibit
replic
wherea
effect
treatment
hpi
significantli
attenu
fig
transfect
subgenom
replicon
rna
lack
region
rdshcontrol
rdshcypa
cell
found
rna
replic
insid
host
cell
affect
downregul
cypa
fig
result
indic
cypa
affect
earli
step
genom
replic
infect
detect
viral
rna
differ
time
point
rd
cell
infect
viru
found
amount
rna
rdshcypa
cell
decreas
less
rdshcontrol
cell
hpi
fig
start
point
reduct
revers
rdshcypa
cell
infect
viru
fig
detect
express
found
express
clearli
consist
attenu
rdshcypa
cell
comparison
rdshcontrol
cell
hpi
fig
moreov
augment
viru
rna
rdshcontrol
cell
indic
replic
rna
began
hpi
fig
black
line
contrast
stage
obvious
delay
hpi
rdshcypa
cell
fig
red
line
howev
infect
rd
rdshcypa
cell
growth
curv
reveal
similar
curv
indic
mutant
confer
resist
cypa
deplet
fig
check
viral
titer
cultur
found
viral
titer
supernat
clearli
alter
rdshcypa
rdshcontrol
cell
fig
also
infect
rd
cell
use
mm
treatment
measur
viral
titer
supernat
differ
hpi
fig
result
show
infecti
viral
product
affect
inhibitor
hpi
significantli
impact
intracellular
viral
genom
hpi
thu
specul
cypa
deplet
block
viral
entri
reinfect
left
virus
cultur
examin
intern
use
immunofluoresc
fig
rdshcontrol
rdshcypa
cell
infect
wtand
endogen
cypa
protein
analyz
immunofluoresc
rdshcontrol
cell
infect
distribut
throughout
cytoplasm
hpi
indic
viru
particl
intern
local
cypa
random
fig
panel
ac
downregul
cypa
rdshcypa
cell
first
confirm
fig
rdshcypa
cell
infect
local
restrict
cytoplasm
perimembran
region
hpi
fig
panel
df
also
observ
coloc
cypa
suggest
knockdown
cypa
inhibit
intern
cypa
accumul
around
virion
contrast
intern
rescu
mutant
fig
panel
gi
similar
observ
also
report
pseudoviru
presenc
cypa
inhibitor
data
indic
cypa
deplet
inhibit
intern
host
cell
treat
cypa
enhanc
bind
virion
function
receptor
entri
divid
follow
two
process
receptor
bind
uncoat
releas
viral
genom
demonstr
exact
function
cypa
entri
first
check
effect
cypa
downregul
bind
virion
host
cell
result
show
bind
host
cell
attenu
cypa
knockdown
fig
could
rescu
substitut
prolin
residu
attenu
attenu
fig
check
bind
affin
three
report
function
receptor
ie
hs
virion
without
cypa
treatment
result
reveal
cypa
treatment
lead
obviou
upregul
bind
function
receptor
fig
togeth
result
show
cypa
directli
interact
virion
cypa
treatment
like
enhanc
bind
report
receptor
attenu
virion
bind
rdshcypa
compens
mutat
like
result
interact
chang
virion
cypa
locat
cell
membran
data
genom
express
percentag
rna
untreat
control
cell
mrna
level
gapdh
use
intern
control
data
viral
titer
supernat
measur
previous
describ
b
subgenom
replicon
rna
transfect
rdshcontrol
rdshcypa
cell
luciferas
level
quantifi
measur
firefli
luciferas
activ
rel
luminesc
unit
hpi
firefli
luciferas
activ
use
intern
control
growth
curv
c
rdshcontrol
rdshcypa
cell
moi
infect
quantifi
use
qrtpcr
detect
rna
cypa
uncoat
regul
entri
convers
particl
particl
induc
uncoat
acid
condit
howev
recent
biochem
structur
studi
suggest
simpli
heat
particl
near
induc
viru
expans
rna
genom
releas
heat
lead
subsequ
protein
melt
virion
uncoat
next
use
previous
report
virion
flotat
assay
use
detect
convers
particl
form
viral
uncoat
check
whether
uncoat
process
entri
could
affect
cypa
consist
virion
treat
exhibit
smaller
shift
fig
blue
line
nativ
peak
fig
black
line
ultracentrifug
gml
discontinu
cscl
gradient
wherea
virion
treat
exhibit
much
larger
shift
fig
red
line
next
incub
virion
mg
recombin
cypa
follow
incub
h
ph
rdshcontrol
rdshcypa
cell
differ
time
post
infect
mrna
level
gapdh
use
intern
control
data
repres
mean
three
independ
experi
error
bar
repres
sem
e
express
also
check
rdshcontrol
rdshcypa
cell
immunoblot
analysi
f
viral
titer
supernat
measur
differ
time
post
infect
g
subcellular
local
cypa
immunofluoresc
analysi
perform
rdshcontrol
rdshcypa
cell
infect
wtor
moi
hpi
cell
fix
stain
anticypa
panel
e
green
panel
c
g
k
red
antibodi
dapi
use
visual
nuclei
panel
b
f
j
blue
panel
ad
eh
il
show
cell
merg
imag
shown
panel
h
l
respect
ph
respect
subject
ultracentrifug
rpm
h
result
reveal
cypa
trigger
convers
particl
ph
ph
fig
contrari
mixtur
particl
cypa
incub
ph
h
shift
particl
distinct
fig
black
red
line
moreov
catalyticdefect
mutant
cypa
name
incub
particl
ph
h
shift
virion
complet
elimin
fig
blue
line
result
support
idea
cypa
regul
uncoat
process
entri
phdepend
manner
play
similar
role
uncoat
receptor
mutat
decreas
viral
fit
confer
cypa
inhibitor
resist
studi
fit
mutat
hi
loop
transfect
rd
cell
rna
transcript
recombin
contain
code
mutat
gener
recombin
virus
design
fig
comparison
almost
equal
supernat
infect
titer
p
p
respect
slightli
lower
infect
titer
p
p
respect
fig
find
indic
prolin
residu
locat
hi
loop
act
interact
cypa
lead
correct
conform
viral
capsid
viru
uncoat
notabl
supernat
infect
titer
log
lower
p
fig
intracellular
growth
curv
show
growth
also
slower
fig
howev
infect
rd
cell
virus
mm
treatment
found
growth
much
better
fig
find
consist
result
infect
rdshcypa
cell
fig
togeth
result
suggest
replac
prolin
residu
decreas
viral
fit
confer
resist
cypa
inhibitor
caus
cypa
loss
function
result
report
demonstr
cypa
host
factor
play
crucial
role
uncoat
process
entri
step
infect
action
site
cypa
map
hi
loop
capsid
protein
analysi
sequenc
genbank
show
action
posit
cypa
hi
loop
strictli
conserv
genotyp
stain
fig
either
protein
sequenc
gene
codon
howev
comparison
sever
repres
strain
coxsacki
viru
cv
polioviru
pv
ev
suggest
posit
conserv
among
pv
fig
depend
prolifer
enterovirus
picornavirus
host
factor
must
defin
crystal
structur
matur
particl
reveal
hi
loop
mostli
solventexpos
region
surfac
viru
particl
fig
usual
function
receptor
bind
uncoat
among
report
function
receptor
one
mediat
attach
host
cell
uncoat
induc
convers
matur
particl
form
viral
uncoat
process
recent
result
nishimur
et
al
report
hi
loop
play
essenti
role
recognit
one
function
receptor
name
demonstr
substitut
locat
hi
loop
significantli
attenu
viru
bind
also
indic
residu
modul
orient
thu
regul
exposur
posit
charg
lysin
side
chain
turn
regul
receptor
bind
moreov
tan
et
al
show
bind
heparan
sulfat
cell
surfac
suggest
heparan
sulfat
may
bind
posit
charg
amino
acid
includ
form
cluster
around
fivefold
symmetri
axi
find
suggest
lysin
residu
posit
play
essenti
role
bind
viru
variabl
receptor
interestingli
two
lysin
residu
surprisingli
close
cypa
action
site
hi
loop
fig
recent
result
lee
et
al
report
neutral
antibodi
call
epitop
fivefold
vertex
cover
hi
loop
studi
support
critic
role
correct
hi
loop
conform
entri
step
contrast
bind
site
virion
map
canyon
around
residu
far
away
observ
virion
bind
enhanc
slightli
decreas
cypa
treatment
suggest
cypa
function
entri
could
complic
taken
togeth
propos
cypa
play
role
uncoat
regul
alter
conform
hi
loop
entri
hsmediat
pathway
cypa
differ
impact
entri
variou
function
receptor
anoth
interest
observ
cypa
mediat
uncoat
distinctli
ph
ph
viru
intern
endosom
acidif
increas
matur
valu
rang
ph
earli
endosom
ph
late
endosom
previous
shown
mediat
uncoat
effici
ph
propos
cypa
act
mediat
uncoat
matur
late
endosom
increas
matur
late
endosom
acidif
uncoat
regul
transfer
cypa
next
one
name
similar
observ
also
found
cypa
studi
hpv
entri
cypa
treatment
induc
releas
capsid
protein
phdepend
manner
dissoci
effici
ph
less
effici
ph
undetect
ph
suggest
complic
process
viru
uncoat
endosom
furthermor
cypa
show
complic
impact
life
cycl
cypa
necessari
infect
also
block
uncoat
reveal
previou
report
simpli
exclud
possibl
cypa
may
associ
entri
might
also
affect
intracellular
step
protein
translat
assembl
secret
addit
effect
entri
step
result
actual
found
viru
prolifer
slowli
without
cypa
inhibitor
treatment
although
mutant
enhanc
interact
virion
cypa
moreov
infect
rdshcypa
cell
although
intracellular
genom
rna
protein
level
much
lower
rdshcontrol
cell
supernat
viru
titer
exhibit
signific
differ
interestingli
downregul
cypb
attenu
actual
increas
rna
replic
express
fig
express
endogen
cypb
also
upregul
infect
fig
moreov
mutant
recov
rna
replic
protein
express
rdshcypa
cell
present
discrep
rdshcypb
cell
ie
slightli
increas
rna
replic
decreas
protein
express
fig
interestingli
two
recent
work
reveal
cyp
inhibit
prolifer
viru
opposit
previous
identifi
posit
function
cyp
life
cycl
find
indic
cyp
may
multipl
function
life
cycl
may
addit
oppos
effect
viral
assembl
secret
find
requir
valid
work
describ
highlight
new
function
cypa
uncoat
regul
prolifer
facilit
conform
shift
hi
loop
result
significantli
increas
understand
virushost
interact
provid
addit
target
action
csaderiv
antivir
without
immunosuppress
activ
current
clinic
trial
treat
rd
cell
human
embryon
rhabdomyosarcoma
cell
line
purchas
atcc
cell
kindli
given
jin
zhong
institut
pasteur
shanghai
chines
academi
scienc
cell
grown
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
bovin
serum
fb
gibco
humidifi
incub
co
plasmid
contain
human
strain
brcr
kindli
provid
prof
bo
zhang
wuhan
institut
virolog
plasmid
contain
human
strain
contain
gfp
report
gene
insert
genom
donat
prof
satoshi
koik
tokyo
metropolitan
institut
medic
scienc
plasmid
subgenom
replicon
rna
given
prof
wenhui
li
nation
institut
biolog
scienc
plasmid
given
prof
linqi
zhang
school
medicin
tsinghua
univers
virus
amplifi
rd
cell
quantifi
make
determin
tissu
cultur
infect
dose
tcid
per
ml
rd
cell
previous
describ
use
experi
mous
monoclon
antibodi
abcam
cat
use
detect
viru
experi
rabbit
anticypa
monoclon
antibodi
cat
rabbit
anticypb
monoclon
antibodi
cat
purchas
abcam
antigapdh
monoclon
antibodi
antigst
monoclon
antibodi
purchas
jiamei
china
secondari
antibodi
use
western
blot
analysi
immunofluoresc
purchas
southern
biotech
hrpconjug
goat
antimous
igg
h
l
cowin
bioscienc
hrpconjug
goat
antirabbit
igg
santa
cruz
peconjug
goat
antimous
igg
life
technolog
donkey
antirat
igg
hl
cyclophilin
inhibitor
known
csa
purchas
sigma
compound
gener
provid
prof
jian
li
inhibitor
initi
dissolv
dmso
stock
solut
store
immedi
addit
compound
dilut
desir
concentr
dmem
fb
trizol
reagent
super
script
iii
firststrand
synthesi
system
rtpcr
kit
purchas
invitrogen
mega
script
high
yield
transcript
kit
purchas
ambion
quantitect
sybr
green
rtpcr
kit
purchas
qiagen
cell
viabil
prolifer
assay
purchas
roch
rna
transcript
subgenom
replicon
obtain
use
mega
script
high
yield
transcript
kit
ambion
dna
linear
sali
xbali
neb
digest
use
templat
accord
manufactur
protocol
vitro
transcrib
rna
transfect
rd
cell
monolay
mm
mm
dish
lipofectamin
invitrogen
cell
incub
ml
dmem
contain
fb
per
dish
cytopath
effect
cpe
rd
cell
observ
h
post
transfect
cell
exhibit
cpe
cell
supernat
collect
centrifug
rpm
min
target
virus
store
viru
titer
determin
use
endpoint
dilut
assay
epda
focusform
unit
ffu
readout
brief
measur
perform
seed
rd
cell
per
well
microtit
plate
overnight
cultur
virus
serial
dilut
dmem
contain
fb
fold
dilut
ad
rd
cell
plate
incub
co
cpe
observ
microscop
day
post
infect
gfp
express
level
monitor
fluoresc
microscop
day
post
infect
viru
titer
express
tcid
determin
epda
total
cellular
rna
isol
trizol
reagent
accord
standard
protocol
follow
primer
sequenc
use
qrtpcr
gapdh
forward
primer
revers
primer
forward
primer
revers
primer
qrtpcr
perform
quantitect
sybr
green
rtpcr
kit
qiagen
gapdh
transcript
level
determin
ddct
method
determin
amount
purifi
virion
viral
rna
extract
ml
pb
buffer
contain
virion
use
trizol
ls
reagent
invitrogen
determin
amount
virion
cscl
fraction
viral
rna
extract
ml
cscl
fraction
contain
virion
addit
ml
nucleasefre
water
trizol
ls
reagent
invitrogen
plasmid
use
standard
sampl
gener
standard
curv
rang
copiesml
rna
copi
quantifi
use
quantitect
sybr
green
rtpcr
kit
qiagen
antivir
activ
compound
determin
use
qrtpcrbase
assay
viru
rd
cell
brief
rd
cell
seed
well
tissu
cultur
plate
allow
attach
complet
cultur
medium
overnight
cultur
medium
replac
medium
contain
serial
dilut
compound
presenc
fb
dmso
h
rd
cell
infect
multipl
infect
moi
indic
figur
legend
compound
ad
indic
concentr
total
cellular
rna
isol
use
trizol
reagent
accord
standard
protocol
hpi
qrtpcr
assay
perform
describ
gapdh
transcript
level
determin
ddct
method
ic
valu
repres
concentr
compound
rna
level
rd
cell
reduc
monitor
cytotox
effect
compound
viabil
rd
cell
determin
h
compound
treatment
viabil
determin
tissu
cultur
plate
use
cell
prolifer
reagent
roch
data
point
repres
averag
three
replic
ec
cytotox
valu
plot
use
graphpad
prism
softwar
rd
cell
seed
cellswel
plate
follow
day
medium
remov
replac
dmem
contain
fb
mm
dmso
use
control
h
strain
use
infect
rd
cell
moi
complet
medium
contain
inhibitor
cours
select
rd
cell
split
reach
confluenc
fresh
complet
medium
contain
inhibitor
ad
cell
cultur
split
viral
replic
presenc
compound
monitor
determin
cytopath
effect
cpe
passag
virus
demonstr
appar
cpe
approxim
day
infect
medium
contain
inhibitor
day
medium
contain
dmso
cell
supernat
collect
follow
centrifug
g
min
store
passag
viru
rd
cell
treat
cyclophilin
inhibitor
h
infect
viru
condit
describ
experi
repeat
cycl
cell
supernat
collect
passag
viru
rd
cell
lyse
trizol
reagent
cypa
cypb
stabl
knockdown
rd
cell
line
produc
previous
describ
modif
follow
shrna
sequenc
use
studi
nc
cypa
cypb
shrna
recombin
lentivirus
lvcypa
lvcypb
produc
shanghai
genepharma
viru
titer
determin
tuml
rd
cell
infect
moi
shrna
recombin
lentiviru
incub
mgml
polybren
enhanc
lentiviru
infect
knockdown
cell
line
confirm
h
post
infect
western
blot
analysi
stabl
knockdown
cell
line
rd
cell
incub
select
medium
contain
mgml
puromycin
invitrogen
begin
h
transduct
cypa
cypb
knockdown
stabl
approxim
two
week
cell
cultur
infect
immunofluoresc
assay
sirna
knockdown
cyp
rd
cell
cypa
knockdown
cell
grown
cover
slip
cell
reach
confluenc
cell
infect
viru
cell
wash
pb
indic
time
post
infect
fix
paraformaldehyd
min
room
temperatur
wash
permeabil
triton
pb
min
cell
wash
block
normal
goat
serum
pb
min
follow
h
incub
primari
antibodi
dilut
room
temperatur
three
wash
pb
cell
incub
fitcor
peconjug
secondari
antibodi
dilut
h
extens
wash
pb
cell
nuclei
stain
dapi
imag
captur
use
confoc
microscop
olympu
fluoview
confoc
microscop
oper
fluoview
softwar
microscop
set
exposur
time
use
within
individu
experi
gene
encod
hi
loop
residu
hi
loop
substitut
residu
human
cypa
catalyticdefect
mutant
cypa
clone
express
vector
gst
tag
fuse
nterminu
accord
gener
protocol
accuraci
insert
verifi
sequenc
plasmid
transform
e
coli
cell
transform
cell
cultur
lb
media
contain
mgl
ampicillin
od
reach
cultur
cool
recombin
protein
express
induc
overnight
induct
cell
harvest
centrifug
pellet
resuspend
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
follow
homogen
use
ultrahighpressur
cell
disrupt
jnbio
guangzhou
china
insolubl
materi
remov
centrifug
g
supernat
load
twice
onto
gst
column
preequilibr
lysi
buffer
load
gst
column
wash
least
column
volum
lysi
buffer
remov
unbound
protein
bead
contain
recombin
gstcypa
gst
protein
ad
eppendorf
tube
store
use
obtain
recombin
human
cypa
without
gst
tag
gst
tag
cypa
remov
overnight
incub
presciss
proteas
target
protein
elut
lysi
buffer
elut
target
protein
purifi
gel
filtrat
chromatographi
ge
healthcar
remov
contamin
fraction
analyz
sdspage
final
puriti
immunoblot
analysi
cell
lyse
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
nonidet
sd
mm
edta
proteas
inhibitor
protein
concentr
lysat
determin
spectrophotomet
protein
resolv
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
membran
millipor
membran
block
h
nonfat
dri
milk
solut
trisbuff
salin
membran
blot
specif
primari
antibodi
follow
incub
secondari
antibodi
conjug
horseradish
peroxidas
protein
visual
chemiluminesc
use
clariti
western
ecl
substrat
biorad
allow
pulldown
assay
detect
interact
cypa
virion
incub
ml
strain
brcr
ml
glutathionesepharos
bead
contain
gst
mg
gstcypa
mg
ml
immunoprecipit
buffer
mm
trishcl
ph
mm
nacl
nonidet
mm
edta
proteas
inhibitor
overnight
bead
wash
three
time
pb
complex
elut
glutathionesepharos
bead
reduc
glutathion
gsh
solut
move
supernat
new
eppendorf
tube
ad
sd
load
buffer
incub
supernat
boil
water
min
subject
sampl
sdspage
follow
western
blot
analysi
mous
antibodi
gst
detect
interact
cypa
recombin
human
cypa
express
purifi
concentr
mgml
recombin
human
cypa
mg
incub
ml
glutathionesepharos
bead
contain
gst
mg
mg
mg
ml
immunoprecipit
buffer
describ
reaction
incub
overnight
wash
bead
three
time
pb
elut
complex
glutathionesepharos
bead
reduc
gsh
solut
sampl
subject
western
blot
analysi
describ
use
mous
antibodi
gst
cypa
band
quantifi
imagej
softwar
time
addit
effect
examin
rd
cell
per
well
ml
fbsdmem
medium
cultur
co
plate
overnight
cell
subsequ
treat
mm
either
concurr
h
moi
interv
hpi
incub
h
antivir
activ
determin
measur
percentag
rna
untreat
control
cell
mrna
level
gapdh
use
intern
control
supernat
viru
titer
express
tcid
determin
epda
viru
bind
assay
perform
use
previous
report
protocol
modif
brief
rd
cell
seed
rd
cellswel
plate
follow
day
cultur
medium
remov
cell
wash
cold
phosphatebuff
salin
pb
ml
bind
buffer
pb
contain
bsa
sodium
azid
ad
cell
ice
incub
min
supernat
subsequ
remov
cell
stock
strain
tcid
ml
prepar
previous
mention
viru
dilut
ml
dmem
complet
medium
dilut
fold
tcid
tcid
per
well
ad
cell
h
incub
ice
unbound
viru
remov
three
wash
step
ml
pb
cell
lyse
well
ml
trizol
viral
rna
extract
detect
qrtpcr
viru
bind
assay
systemat
perform
duplic
two
individu
experi
perform
condit
bind
assay
virus
hs
viru
bind
assay
perform
accord
previous
report
protocol
detect
influenc
cypa
hs
viru
interact
ml
strain
ticd
incub
without
cypa
h
supernat
ad
ml
hitrap
heparin
hp
column
ge
healthcar
sweden
previous
equilibr
bind
buffer
trishcl
nacl
ph
flow
rate
approxim
mlmin
load
two
column
wash
least
column
volum
bind
buffer
remov
unbound
viru
bound
viral
particl
elut
use
elut
buffer
trishcl
nacl
ph
fraction
ml
collect
rna
isol
quantifi
use
qrtpcr
method
describ
purifi
cypa
also
upload
hitrap
heparin
hp
show
detect
interact
cypa
column
data
shown
detect
cypa
influenc
viru
interact
strain
ticd
incub
without
recombin
human
cypa
mg
ml
dmem
h
human
mg
r
system
human
igg
fc
mg
control
ad
assay
reaction
incub
h
protein
gagaros
ml
roch
ad
mixtur
tube
shaken
overnight
detect
cypa
treatment
effect
viru
interact
strain
ticd
incub
without
recombin
human
cypa
mg
ml
dmem
h
mg
quantiti
ad
assay
reaction
incub
h
ninta
bead
ml
ad
mixtur
tube
shaken
overnight
bead
wash
three
time
pb
elut
ml
elut
buffer
contain
mm
trishcl
ph
mm
nacl
imidazol
rna
supernat
isol
trizol
ls
reagent
quantifi
use
qrtpcr
method
describ
purif
virion
perform
use
previous
report
protocol
modif
brief
rd
cell
five
cell
cultur
flask
infect
strain
moi
cultur
fb
cell
exhibit
cpe
supernat
collect
concentr
filtrat
kdacutoff
centrifug
filter
millipor
concentr
viru
mix
gml
cscl
volum
ration
load
middl
cscl
gradient
gml
gml
gml
gml
gml
discontinu
follow
ultracentrifug
rpm
h
beckman
rotor
dialyz
pb
purifi
viru
quantifi
store
rna
copi
purifi
viru
quantifi
previous
describ
virion
flotat
assay
cscl
densiti
gradient
centrifug
fifti
ml
purifi
viru
genom
copi
incub
mg
purifi
wt
cypa
catalyticdefect
mutant
cypa
pb
contain
bsa
total
volum
ml
low
ph
treatment
hcl
ad
mixtur
bring
ph
valu
mixtur
incub
h
subsequ
appli
gml
discontinu
cscl
gradient
ultracentrifug
rpm
h
beckman
rotor
sampl
analyz
qrtpcr
transit
state
viral
particl
uncoat
perform
vitro
nativ
virion
heat
min
low
salt
buffer
contain
mm
cacl
mm
hepe
ph
figur
recombin
cypa
catalyz
cistran
reaction
chemic
synthes
peptid
shift
nmr
spectra
indic
conform
peptidylprolin
chang
mhz
h
nmr
spectra
peptid
ph
concentr
peptid
mm
without
cypa
treatment
without
cypa
treatment
c
b
cypa
treatment
concentr
mm
h
signal
mark
orthoproton
signal
pnitroanilid
peptid
repres
signal
ci
isom
chemic
shift
ppm
tran
isom
chemic
shift
approxim
ppm
integr
area
respect
peak
use
upper
numer
valu
peptid
sequenc
gsskskypl
peptid
sequenc
gsskpkypl
tif
tabl
amino
acid
chang
emerg
select
compound
repres
three
individu
select
experi
cypa
inhibitorresist
viru
doc
tabl
csa
resist
level
sitedirect
chang
engin
viru
substitut
confer
resist
rd
cell
incub
h
variou
concentr
compound
mm
csa
mm
infect
viru
moi
rna
level
quantifi
rtqpcr
data
point
repres
averag
three
replic
text
support
inform
nmr
measur
cypa
activ
pplase
activ
recombin
activ
measur
previous
describ
nmr
method
brief
recombin
cypa
protein
use
nmr
experi
diafilt
mm
phosphat
buffer
ph
concentr
stock
concentr
mm
substrat
peptid
chemic
synthes
dissolv
concentr
mm
buffer
contain
mm
sodium
phosphat
ph
recombin
cypa
protein
final
concentr
mm
ad
substrat
peptid
mixtur
incub
h
solut
use
lock
sampl
nmr
spectromet
aliquot
ad
mm
nmr
tube
h
nmr
measur
perform
mhz
mhz
nmr
spectromet
acquir
data
process
mestrenova
softwar
doc
